Back to today’s briefing

Story perspectives

Trump Administration Shifts 340B Drug Pricing to Rebate Model

8/5/2025

50 11

Summary

Story summary

In 2024, the Trump administration will initiate a pilot program to transform the 340B drug pricing initiative from upfront discounts to a rebate model. This shift seeks to curb hospital misuse while inviting drugmakers to join the conversation. However, the potential effects on hospitals and patients hang in the balance as discussions about the program's integrity continue.

1 of 1

Story summary

In 2024, the Trump administration will initiate a pilot program to transform the 340B drug pricing initiative from upfront discounts to a rebate model. This shift seeks to curb hospital misuse while inviting drugmakers to join the conversation. However, the potential effects on hospitals and patients hang in the balance as discussions about the program's integrity continue.